ADXN Competitors & Alternatives
Compare Addex Therapeutics Ltd with similar stocks in the same industry
Biotechnology
ADXN
Main Stock$3.10
Tradestie Score
49
Market Cap
$8.71M
Revenue Growth
-0.7%
Analyst Upside
+867.7%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.04
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.31
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.02
|
$110.20M | - | 61 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.65
|
$84.52M | - | 59 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.10
|
$67.94M | - | 45 | Compare |
|
BCDA
BioCardia, Inc. Common Stock
|
$1.06
|
$14.11M | - | 49 | Compare |
|
KZIA
Kazia Therapeutics Limited American Depositary Shares
|
$9.45
|
$11.44M | - | 51 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$1.12
|
$3.50M | - | 61 | Compare |
|
AFIB
AFIB
|
- | - | - | - | Compare |
|
NMAD
NMAD
|
$3.99
|
- | - | 49 | Compare |
More ADXN Analysis
Data updated: Oct 05, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry